Thursday, October 4, 2012

Taiho gains approval for Zosyn in additional indications in Japan

Taiho Pharmaceutical Co., Ltd. announced today that ZOSYN 2.25 and ZOSYN 4.5 for intravenous injection (generic name: tazobactam and piperacillin for injection), received an approval of new indications for the treatment of peritonitis, intra-abdominal abscess, cholecystitis, and cholangitis in Japan.
Taiho Pharmaceutical Co., Ltd. holds the marketing authorization of ZOSYN® in Japan and Taisho Toyama Pharmaceutical Co., Ltd. is marketing the product. ZOSYN is currently available in approximately 90 countries.